European Study in Patients With Osteoarthritis, Rheumatoid Arthritis, or Ankylosing Spondylitis at Gastrointestinal Risk: A Retrospective, Non-interventional Study of Vimovo Prescribing Patterns

Trial Profile

European Study in Patients With Osteoarthritis, Rheumatoid Arthritis, or Ankylosing Spondylitis at Gastrointestinal Risk: A Retrospective, Non-interventional Study of Vimovo Prescribing Patterns

Completed
Phase of Trial: Phase IV

Latest Information Update: 04 Jun 2014

At a glance

  • Drugs Esomeprazole/naproxen (Primary)
  • Indications Ankylosing spondylitis; Musculoskeletal pain; NSAID-induced gastrointestinal damage; Osteoarthritis; Rheumatoid arthritis
  • Focus Therapeutic Use
  • Acronyms CHARACTERIZE
  • Sponsors AstraZeneca
  • Most Recent Events

    • 08 Apr 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
    • 03 Oct 2013 Planned End Date changed from 1 Jun 2013 to 1 Mar 2014 as reported by ClinicalTrials.gov.
    • 02 Feb 2012 Status changed from not yet recruiting to recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top